Expanding research in neuromuscular disease: highlights and expert commentary from WMS 2022

At the 27th congress of the World Muscle Society, new data were presented on novel therapies, biomarkers, and the impact of digital technology on the care of people with neuromuscular disease.

Here, Dr Jiri Vajsar (Clinical Director, The Hospital for Sick Children, Toronto, Canada, and Co-Chair of WMS 2022) comments on selected highlights from the congress, held in Halifax, Canada, on 11-15 October 2022. For more from WMS 2022, see Neurodiem’s daily coverage of the event.